• Type II DM:
    • HbA1c <8% or treatment-naïve:
      • Initially PO 0.5mg 15-30min before each meal
      • Maintenance: PO 0.5-4mg
      • May double preprandial dose no more frequently than once weekly
      • Max: 4mg/dose up to 16mg/day
    • HbA1c >8% or treatment-experienced:
      • Initially 1-2mg every 15-30min before each meal
      • Maintenance: PO 0.5-4mg
      • May double preprandial dose no more frequently than once weekly
      • Max: 4mg/dose up to 16mg/day
  • Tablet:
    • 0.5mg
    • 1mg
    • 2mg
  • Dose taken 15-30 minutes before meal
  • In case of skipped meals, skip the scheduled repaglinide dose to reduce the risk of hypoglycemia

Meglitinide antidiabetics

It stimulates pancreatic islet beta cell insulin release, lowering serum glucose levels

  • Hypoglycemia
  • URI symptoms
  • Headache
  • Arthralgia
  • Diarrhea
  • Back pain
  • Nausea
  • Vomiting
  • Constipation
  • Dyspepsia
  • Paresthesia
  • Chest pain
  • UTI
  • Tooth disorder
  • Hypersensitivity to class/components
  • Diabetic ketoacidosis
  • Type I DM
  • Gemfibrozil

                          Drug Status

Availability Prescription only
Pregnancy Category C
Breastfeeding Contraindicated
Schedule Not controlled
BRAND NAME STRENGTH FORMULATION PACK SIZE MANUFACTURER DISTRIBUTOR
Novonorm 0.5mg Tablet 30’s Novo Nordisk Phillips Therapeutics
Novonorm 1mg Tablet 30’s Novo Nordisk Phillips Therapeutics
Novonorm 2mg Tablet 30’s Novo Nordisk Phillips Therapeutics